Michael is a former senior executive of Amgen Inc. and is currently acting as Founder & President of Sentry Hill Partners, LLC, a global life sciences transformation and management consulting business that he founded in 2018. He has more than two decades of executive experience as a senior leader in the life sciences industry, serving in various strategic finance and operations positions at Amgen Inc., most recently as Senior Vice President, Global Business Services and Vice President & CFO, International Commercial Operations.

Stephen has over 35 years of experience in the global life sciences and biotechnology industries. He is currently General Counsel, Commercial of GE HealthCare, a business unit of General Electric that provides medical technologies and solutions to the global healthcare industry. He was previously General Counsel for GE HealthCare’s Life Sciences business and its Global Innovations group. He joined GE HealthCare after various in-house general counsel and compliance officer roles in the pharmaceutical industry.

Alison has served as a director since June 2015. She has over 25 years of experience in the development of investigational cancer chemotherapies. Since 2000, she has served as a consultant to the pharmaceutical industry, working with over 20 companies with a focus on molecularly targeted therapy. Prior to this, she worked as Senior Medical Director at SUGEN on various compounds, including SUTENT® (sunitinib malate), and Quintiles (now IQVIA), a global contract research organization.

With over 30 years of diagnostics and medical device experience, Neil has a comprehensive knowledge of the global diagnostic and sequencing markets. He brings direct experience of commercial operations; product launches; product development; clinical, quality, and regulatory processes; and strategy development.